| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |